S unscreen industry stakeholders facing the potential loss of UV flters under FDA’s OTC drug review could have much to gain from the antibacterial soap sector, which is about half- way into a fve-year work plan to keep priority germ-killing ingre- dients available on an OTC basis.
展开▼